1. Home
  2. QGEN vs FRHC Comparison

QGEN vs FRHC Comparison

Compare QGEN & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QGEN
  • FRHC
  • Stock Information
  • Founded
  • QGEN 1986
  • FRHC N/A
  • Country
  • QGEN Netherlands
  • FRHC United States
  • Employees
  • QGEN N/A
  • FRHC N/A
  • Industry
  • QGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • FRHC Investment Bankers/Brokers/Service
  • Sector
  • QGEN Health Care
  • FRHC Finance
  • Exchange
  • QGEN Nasdaq
  • FRHC Nasdaq
  • Market Cap
  • QGEN 10.8B
  • FRHC 11.0B
  • IPO Year
  • QGEN 1996
  • FRHC N/A
  • Fundamental
  • Price
  • QGEN $48.00
  • FRHC $180.00
  • Analyst Decision
  • QGEN Buy
  • FRHC
  • Analyst Count
  • QGEN 8
  • FRHC 0
  • Target Price
  • QGEN $51.01
  • FRHC N/A
  • AVG Volume (30 Days)
  • QGEN 1.7M
  • FRHC 159.3K
  • Earning Date
  • QGEN 08-05-2025
  • FRHC 08-15-2025
  • Dividend Yield
  • QGEN 3.18%
  • FRHC N/A
  • EPS Growth
  • QGEN 405.07
  • FRHC N/A
  • EPS
  • QGEN 1.69
  • FRHC 1.40
  • Revenue
  • QGEN $2,040,067,000.00
  • FRHC $1,462,948,000.00
  • Revenue This Year
  • QGEN $6.41
  • FRHC N/A
  • Revenue Next Year
  • QGEN $5.70
  • FRHC N/A
  • P/E Ratio
  • QGEN $28.05
  • FRHC $135.81
  • Revenue Growth
  • QGEN 5.15
  • FRHC 33.85
  • 52 Week Low
  • QGEN $37.63
  • FRHC $82.08
  • 52 Week High
  • QGEN $51.88
  • FRHC $194.01
  • Technical
  • Relative Strength Index (RSI)
  • QGEN 44.29
  • FRHC 60.94
  • Support Level
  • QGEN $47.45
  • FRHC $174.62
  • Resistance Level
  • QGEN $50.27
  • FRHC $194.01
  • Average True Range (ATR)
  • QGEN 0.90
  • FRHC 6.35
  • MACD
  • QGEN -0.40
  • FRHC 0.49
  • Stochastic Oscillator
  • QGEN 8.80
  • FRHC 60.42

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

Share on Social Networks: